MOLAR INCISOR HYPOMINERALIZATION

cocukdishekimligiozel11-1-25kapakv2

Molar Incisor Hypomineralization and Immunological Diseases

Nesrin DEMİRa
aAntalya Bilim University Faculty of Dentistry, Department of Immunology, Antalya, Türkiye

Demir N. Molar incisor hypomineralization and immunological diseases. In: Şen Tunç E, ed. Molar Incisor Hypomineralization. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.86-90.

ABSTRACT
Immunological diseases are caused by defects in one or more components of the immune system or by abnormal, excessive and uncontrolled immune responses. Immunological diseases comprise a clinically heterogeneous group of disorders. Recent investigations have examined the potential relationship between immunological diseases and molar-incisor hypomineralization. Although research in this area remains limited, several studies have demonstrated significant associations between these conditions. Given that dental cells are fundamental to human physiology and systemic conditions during childhood affect developing cells, immunological diseases may potentially impact ameloblasts, the cells responsible for enamel formation. Recognition of the potential connection between dental defects, particularly molar-incisor hypomineralization, and immunological diseases among healthcare professionals could promote a more integrated, multidisciplinary approach to patient care. Inter-professional collaboration is essential for early diagnosis and implementation of strategies to minimize dental sensitivity and discomfort, thereby enhancing patients long-term oral health outcomes and overall quality of life.

Keywords: Dental enamel hypoplasia; immune system diseases; immunology

Referanslar

  1. Jacqueline Parkin, Bryony Cohen. An overview of the immune system. Lancet. 2001; 357: 1777-89. [Crossref]  [PubMed]
  2. Delves PJ, Roitt IM. The immune system. Part 1. N Engl J Med. 2000; 343:3-49. [Crossref]  [PubMed]
  3. Delves PJ, Roitt IM. The immune system. Part 2. N Engl J Med. 2000; 343:108-17. [Crossref]  [PubMed]
  4. Grateau G, Hentgen V, Stojanovic KS, Jéru I, Amselem S, Steichen O. How should we approach classification of autoinflammatory diseases? Nat RevRheumatol. 2013; 9(10):624-9. [Crossref]  [PubMed]
  5. Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382(9894):819-31. [Crossref]  [PubMed]
  6. Ronnblom L, Pascual V. The innate immune system in SLE: Type I interferon and dendritic cells. Lupus. 2008;17(5):394-9. [Crossref]  [PubMed]  [PMC]
  7. Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy ClinImmunol. 2020; 146(5):925-37. [Crossref]  [PubMed]  [PMC]
  8. McGonagle D, McDermott MF. A proposed classification of the Immunological diseases. PLoS Medicine. 2006;3(8): e297. [Crossref]  [PubMed]  [PMC]
  9. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009; 33(3-4):197-207. [Crossref]  [PubMed]  [PMC]
  10. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001; 345(5):340-50. [Crossref]  [PubMed]
  11. Fugger L, Jensen LT, Rossjohn J. Challenges progressa and prospects of developing therapies to treat autoimmune diseases. Cell. 2020; 181(1):63-80. [Crossref]  [PubMed]
  12. Abramson J, Husebye ES. Autoimmune regulator and self-tolerance -molecular and clinical aspects. Immunol Rev. 2016; 271(1):127-40. [Crossref]  [PubMed]
  13. Aksentijevich I, Centola M, Deng ZM, Sood R, Doggett N A. Ancient missense mutations in a new member of the RoRet gene family are likely to cause Familial Mediterranean Fever. Celli. 1997; 90(4):797-807. [Crossref]  [PubMed]
  14. Consortium FF, Candidate A. Gene for Familial Mediterranean Fever. NatGenet. 1997;17(1):25-31. [Crossref]  [PubMed]
  15. Wekell P, Berg S, Karlsson A, Fasth A. Toward an Inclusive, Congruent, and Precise Definition of Autoinflammatory Diseases. Front Immunol. 2017;8:497. [Crossref]  [PubMed]  [PMC]
  16. Krainer J, Siebenhandl S, Weinhausel A. Systemic autoinfammatory diseases. J Autoimmun. 2020; 109:102421. [Crossref]  [PubMed]  [PMC]
  17. Weerheijm KL, Jalevik B, Alaluusua S. Molar-İncisor Hypomineralisation. Caries Res. 2001;35(5):390-1. [Crossref]  [PubMed]
  18. Sundfeld D, da Silva L, Kluppel OJ, Santin GC, de Oliveira Pacheco RR, et al. Molar incisor hypomineralization: etiology, clinical aspects, and a restorative treatment case report. Oper Dent. 2020; 45:343-51. [Crossref]  [PubMed]
  19. Silva MJ, Scurrah KJ, Craig JM, Manton DJ, Kilpatrick N. Etiology of molar incisor hypomineralization. Community Dent Oral Epidemiol. 2016;44(4):342-53. [Crossref]  [PubMed]
  20. Lemanske RF Jr, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125: S95-102 [Crossref]  [PubMed]  [PMC]
  21. Kühnisch J, Mach D, Thiering E, Brockow I, Hoffmann U, Neumann C, et al. Respiratory diseases are associated with molar‐incisor hypomineralizations. Swiss Dent J. 2014;124(3):286-93. [Crossref]  [PubMed]
  22. de Lima MD, Andrade MJ, Dantas‐Neta NB, Andrade NS, Teixeira RJP, de Moura MS, et al. Epidemiologicstudy of molar‐incisor hypomineralization in schoolchildren in North‐eastern Brazil. Pediatr Dent. 2015; 37(7):513-9.
  23. Farah RA, Monk BC, Swain MV, Drummond BK. Protein content ofmolar-incisor hypomineralisation enamel. J Dent. 2010; 38(7):591-6. [Crossref]  [PubMed]
  24. Simmer JP, Fincham AG. Molecular mechanisms of dental enamel formation. Crit Rev Oral Biol Med. 1995;6(2):84-108. [Crossref]  [PubMed]
  25. Sui W, Boyd C, Wright JT. Altered pH regulation during enamel development in the cystic fibrosis mouse incisor. J Dent Res. 2003; 82(5):388-92. [Crossref]  [PubMed]
  26. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ. 2009;181(9): E181-E190. [Crossref]  [PubMed]  [PMC]
  27. Flexeder C, Hassan LK, Standl M, Schulz H, Kühnisch J. Is there anassociation between asthma and dental caries and molar incisor hypomineralisation? Caries Res. 2020;54(1):87-95. [Crossref]  [PubMed]
  28. Ghanim A, Manton D, Marino R, Morgan M, Bailey D. Prevalence of demarcated hypomineralisation defects in second primary molars Iraqi children. Int J Paediatr Dent. 2013;23(1):48‐55. [Crossref]  [PubMed]
  29. Rizzardi KF, da Silva Toledo E, Ferraz LF, Darrieux M, Girardello R, de Lima Marson FA, et al. Association between asthma and enamel defects in primary and young permanent teeth. Pediatric Pulmonology. 2022; 57(1):26-37. [Crossref]  [PubMed]
  30. Caio G, Volta U, Sapone A, Leffler D.A, De Giorgio R, Catassi C.et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17(1):142. [Crossref]  [PubMed]  [PMC]
  31. Singh P, Arora A, Strand T.A, Leffler D.A, Catassi C, Green P.H, et al. Global prevalence of Celiac Disease. Clin Gastroenterol Hepatol. 2018; 16(6):823-836.e822. [Crossref]  [PubMed]
  32. Wieser H, Amato M, Caggiano M, Ciacci C. Dental manifestations and Celiac Disease J. Clin. Med. 2023;12(8):2801. [Crossref]  [PubMed]  [PMC]
  33. Ludvigsson J.F, Leffler D.A, Bai J.C, Biagi F, Fasano A, Green P.H.R, et al. The Oslo definitions for celiac disease and related terms. Gut. 2013;62(1):43-52. [Crossref]  [PubMed]  [PMC]
  34. Hujoel IA, Reilly NR, Rubio-Tapia A. Celiac disease: Clinical features and diagnosis. Gastroenterol Clin N Am. 2019;48(1):19-37. [Crossref]  [PubMed]
  35. Krzywicka B, Herman K, Kowalczyk-Zajac M, Pytrus T. Celiac disease and its impact on the oral health status-review of the literature. Adv Clin Exp Med. 2014;23(5):675-81. [Crossref]  [PubMed]
  36. Muñoz F, Del Río N, Sóñora C, Tiscornia I, Marco A, Hernández A. Enamel defects associated with coeliac disease: putativerole of antibodies against gliadin in pathogenesis. Eur J Oral Sci. 2012;120(2):104-12. [Crossref]  [PubMed]
  37. Sóñora C, Arbildi P, Rodríguez-Camejo C, Beovide V, Marco A, Hernández A. Enamel organ proteins as targets for antibodies in celiac disease: implications for oral health. Eur J Oral Sci. 2016 ;124(1):11-6. [Crossref]  [PubMed]
  38. Petronijevic S, Stig S, Gao J, Halstensen, T.S. Amelogenin specific IgA and IgG in children with untreated coeliac disease. Eur J Oral Sci. 2016;124(6):526-533. [Crossref]  [PubMed]
  39. Petronijevic S, Stig S, Halstensen T.S. Epitope mapping of anti-amelogenin IgA in coeliac disease. Eur J Oral Sci. 2020 ;128(1):27-36. [Crossref]  [PubMed]
  40. Kuklik HH, Cruz ITSA, Celli A, Fraiz FC, da Silva Assunção LR. Hipomineralização de molares e incisivos e doençacelíaca. Arq Gastroenterol. 2020;57(2);167-71. [Crossref]  [PubMed]
  41. Kapur S, Watson W, Carr S. Allergy Asthma, Clin Immunol. 2018;12;14(Suppl 2):52. [Crossref]  [PubMed]  [PMC]
  42. Egawa G, Kabashima K. Multifactorial skin barrier deficiency andatopic dermatitis: essential topics to prevent the atopic march. J Allergy Clin Immunol. 22016 ;138(2):350-358.e1. [Crossref]  [PubMed]
  43. Nakajima S, Kitoh A, Egawa G, Natsuaki Y, Nakamizo S, Moniaga CS, et al. IL-17 A as an inducer for Th2 immune responses in murine atopic dermatitis models. J Invest Dermatol. 2014;134(8):2122-30. [Crossref]  [PubMed]
  44. Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018; 120:131-7. [Crossref]  [PubMed]  [PMC]
  45. Hernandez M, Boj JR, Espasa E, Planells P, Peretz B. Molar-Incisor Hypomineralization: Positive correlation with atopic dermatitis and food allergies. J Clin Pediatr Dent. 2018;42(5):344-8. [Crossref]  [PubMed]
  46. Hernandez M, Mendioroz J. Molar-Incisor Hypomineralisation and Allergic March. Acta Stomatol Croat. 2020;54(2):130-5. [Crossref]  [PubMed]  [PMC]
  47. Guedes‐Pinto AC. Odontopediatria. Vol 4. Rio de Janeiro: Santos; 2016. 836 p.: il.; 28.
  48. Lygidakis N. A. Treatment modalities in children with teeth affected by molar-incisor enamel hypomineralisation (MIH): A systematic review. Eur Archives Paediat Dent 2010; 11: 65-74. [Crossref]  [PubMed]
  49. Ghanim AM, Manton DJ, Morgan MV, Mariño RJ, Bailey DL. Trends of oral health care and dental treatment needs in relation to molar incisor hypomineralisation defects: a study amongst a group of Iraqui children. Eur Arch Paediatr Dent. 2012;13: 171-8. [Crossref]  [PubMed]
  50. Alaluusua S. Aetiology of molar incisor hypomineralisation. Eur Arch Paediatr Dent. 2010;11: 53-8. [Crossref]  [PubMed]